Effect and mechanism of Chaihu jia longgu muli tang-containing serum on inflammatory injury in an epileptic cell model
- VernacularTitle:柴胡加龙骨牡蛎汤含药血清对癫痫细胞模型炎性损伤的影响及机制
- Author:
Ping SHAN
1
;
Chun SUN
1
;
Jilong ZHANG
2
Author Information
1. Dept. of Neurology,Wuhan No. 1 Hospital,Wuhan 430022,China
2. Dept. of Emergency,Wuhan No.1 Hospital,Wuhan 430022,China
- Publication Type:Journal Article
- Keywords:
Chaihu jia longgu muli tang;
Epilepsy;
inflammatory injury;
medicated serum;
STING/TBK1/IRF3 pathway
- From:
China Pharmacy
2026;37(21):2827-2831
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To explore the effect and potential mechanism of Chaihu jia longgu muli tang (CLMT)-containing serum on inflammatory injury in an epileptic cell model based on the stimulator of interferon genes (STING)/TANK-binding kinase 1 (TBK1)/interferon regulatory factor 3 (IRF3) pathway.METHODS Male Wistar rats were administered either saline or 12 g/(kg·d) of CLMT via gavage to prepare blank serum and CLMT-containing serum, respectively. Rat hippocampal neurons were divided into the normal control group, model group, low- and high-concentration CLMT-containing serum groups, and high-concentration CLMT-containing serum+STING agonist group. Except for the normal control group, the epilepsy cell model was established in all other groups by culturing the cells in magnesium ion-free extracellular solution for 3 hours; subsequently, cells in the normal control and model groups were treated with blank serum for 24 hours; cells in the low- and high-concentration CLMT-containing serum groups were treated with 5% and 10% CLMT-containing serum, respectively, for 24 hours; and cells in the high-concentration CLMT-containing serum+STING agonist group were treated with 10% CLMT-containing serum+100 μg/mL DMXAA (STING agonist) for 24 hours. The cell survival rate and apoptosis rate in each group, as well as the levels of inflammatory cytokines (interleukin-1β, interleukin-6 and tumor necrosis factor-α) in the culture medium, and the expressions of proteins related to apoptosis [B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax)] and pathway (STING, TBK1, IRF3) in the cells were detected.RESULTS Compared with the model group, the cell survival rate and protein expression of Bcl-2 were significantly increased or upregulated, while the apoptosis rate, levels of inflammatory cytokines, protein expressions of Bax and STING, Bax/Bcl-2 ratio, and the phosphorylation levels of TBK1 and IRF3 were significantly decreased or downregulated in the low- and high-concentration CLMT-containing serum groups ( P <0.05). Moreover, the improvements of the above indicators in the high-concentration group were superior to those in the low-concentration group ( P <0.05). Compared with the high-concentration CLMT-containing serum group, the above effects were markedly reversed in the high-concentration CLMT-containing serum+STING agonist group ( P <0.05).CONCLUSIONS CLMT-containing serum can promote cell survival, inhibit apoptosis and alleviate inflammatory injury in the epileptic cell model, and its mechanism may be related to the inhibition of STING/TBK1/IRF3 pathway activation.